News from cleave biosciences A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 30, 2015, 08:00 ET

Cleave Biosciences Granted Key U.S. Patent Covering CB-5083

 Cleave Biosciences today announced that the United States Patent and Trademark Office has granted the company a key patent providing the...

Jul 13, 2015, 08:00 ET

Cleave Biosciences Receives Orphan Designation from FDA for CB-5083 for Treatment of Multiple Myeloma

 Cleave Biosciences today announced that its lead drug candidate, CB-5083, has been granted Orphan Drug Designation by the U.S. Food and Drug...

Jun 23, 2015, 08:00 ET

Cleave Biosciences Announces Management Changes

 Cleave Biosciences today announced Kanya Rajangam, M.D., Ph.D. has joined the company as vice president, clinical development. Dr. Rajangam...

Jun 17, 2015, 08:00 ET

Cleave Biosciences to Present at JMP Securities Life Sciences Conference 2015

 Cleave Biosciences today announced that Chief Executive Officer Laura Shawver, Ph.D. will present at the JMP Securities Life Sciences...

Apr 16, 2015, 08:00 ET

Cleave Biosciences to Participate in Special Session "New Drugs on the Horizon" at AACR Annual Meeting 2015

 Scientists from Cleave Biosciences will be participating in the special session, "New Drugs on the Horizon," at the American Association for...

Jan 08, 2015, 08:00 ET

Cleave Biosciences Initiates Phase 1 Clinical Trial of CB-5083 in Patients with Advanced Solid Tumors

 Cleave Biosciences today announced that it has begun a Phase 1 clinical trial to evaluate its lead drug candidate, CB-5083, in patients with...

Sep 04, 2014, 08:00 ET

Cleave Biosciences Initiates Phase 1 Clinical Trial of CB-5083 in Patients with Multiple Myeloma

Cleave Biosciences today announced that it has begun a Phase 1 clinical trial to evaluate its lead drug candidate, CB-5083, in patients with...

Feb 04, 2014, 08:00 ET

Cleave Biosciences Names Alessandra Cesano as Chief Medical Officer and Lewis Shuster as Director

 Cleave Biosciences today announced Alessandra Cesano, M.D., Ph.D. has joined the company as Chief Medical Officer. Dr. Cesano is a board...

Apr 09, 2013, 07:30 ET

Cleave Biosciences Adds New Investor and $10 Million to Series A Financing

Cleave Biosciences announced today it has raised $10 million in an extension of its Series A financing from new investor New Enterprise...

Oct 11, 2011, 08:00 ET

Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies

Cleave Biosciences, a newly established biopharmaceutical company discovering and developing novel therapies for cancer, announced today it has...